|1||NCT01728233||Recruiting||Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis||
||Other / Industry||
||37||Male||18 Years to 75 Years (Adult, Older Adult)||NCT01728233||INT110/12||HER-Uro01||June 15, 2013||October 15, 2017||February 15, 2018||November 19, 2012||March 9, 2017||
|2||NCT02571036||Recruiting||A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies||
||320||All||18 Years and older (Adult, Older Adult)||NCT02571036||DCC-2618-01-001||October 2015||February 2021||February 2021||October 8, 2015||September 17, 2018||
† Study has passed its completion date and status has not been verified in more than two years.